London Daily

Focus on the big picture.
Saturday, Oct 25, 2025

Covid: Oxford-AstraZeneca vaccine safe, says Boris Johnson

Covid: Oxford-AstraZeneca vaccine safe, says Boris Johnson

The Oxford-AstraZeneca vaccine is safe, Boris Johnson has said, adding he will be receiving it himself on Friday.

The benefits of the vaccine preventing Covid far outweighed any risks, the prime minister said, as he urged people to take up the jab when offered.

It comes after UK and EU regulators said there was no evidence the Covid vaccine caused blood clots.

Mr Johnson also said delays to vaccine supply next month would not affect England's roadmap out of lockdown.

"The progress along the road to freedom remains unchecked," he told a Downing Street briefing, after NHS England warned vaccine supplies would be reduced in April.

Prof Chris Whitty, England's chief medical officer, told the briefing the Covid vaccines were "very effective" against what remained a "very dangerous disease for many people".

He added that there were "real issues that we always have to think about with all drugs", but they were "so much smaller than the benefits of getting the vaccine".

"The risk-benefit is really strongly in favour of getting vaccinated," he said.

Regulators have received a very small number of reports of an extremely rare form of blood clot occurring in the brain, prompting some European countries to pause rollout.

But earlier, the MHRA and the EMA said people can have confidence in the vaccine's benefits and should get immunised.

France and Italy have since announced that they will resume using the jab.


A phrase used repeatedly today is the risk-benefit ratio. But what does that mean?

The EU and UK regulators were unable to completely rule out the vaccine as a cause of rare blood clots that have been seen.

Because the clots are so rare, it is hard to tell if they are above the levels you would normally expect without vaccination.

But even if a link is proven - and there is no suggestion it will be - the benefits of vaccination far outweigh the risks.

There have been 18 cases of this rare blood clot out of 20 million vaccinations in Europe. That's about one in a million.

Someone who is over the age of 75 and becomes infected with Covid has a one in nine chance of dying.

Even in younger age groups the benefits are clear. Someone in their 40s has a one in 1,000 risk of dying.

The vaccines have been proved to be highly effective. They will save lives, rather than cost them.

Also during the briefing, Mr Johnson confirmed that supplies of the AstraZeneca vaccine had been affected by a delayed shipment from the Serum Institute of India.

After opening up appointments to all over-50s on Wednesday, the NHS in England was then told not to offer jabs to younger age groups throughout April.

"There is a delay as I have described, as there are very frequently in vaccine rollout programmes," he said.

He put it down to "various technical reasons" and said the Indian government "hasn't stopped any export".

The Serum Institute of India is the world's largest manufacturer of vaccines and is making one billion doses of the AstraZeneca jab this year for low and middle-income countries.

Earlier this month, it agreed to supply 10 million doses for the UK, but only half of these will arrive this month with the rest held up by four weeks.

The Serum Institute said: "Five million doses had been delivered a few weeks ago to the UK and we will try to supply more later, based on the current situation and the requirement for the government immunisation programme in India."

Its chief executive, Adar Poonawalla, has previously called for patience over global vaccine deliveries, saying the company has been "directed to prioritise the huge needs of India".

He has also raised concerns about raw material shortages, attributing this to US export bans on specific items needed to make vaccines, such as specialised bags and filters.



Boris Johnson said England's roadmap out of lockdown will not be disrupted by vaccine supply issues



Newsletter

Related Articles

0:00
0:00
Close
United States and China Begin Constructive Trade Negotiations Ahead of Trump–Xi Summit
U.S. Treasury Sanctions Colombia’s President Gustavo Petro over Drug-Trafficking Allegations
Miss USA Crowns Nebraska’s Audrey Eckert Amid Leadership Overhaul
‘I Am Not Done’: Kamala Harris Signals Possible 2028 White House Run
NBA Faces Integrity Crisis After Mass Arrests in Gambling Scandal
Swift Heist at the Louvre Sees Eight French Crown Jewels Stolen in Under Seven Minutes
U.S. Halts Trade Talks with Canada After Ontario Ad Using Reagan Voice Triggers Diplomatic Fallout
Microsoft AI CEO: ‘We’re making an AI that you can trust your kids to use’ — but can Microsoft rebuild its own trust before fixing the industry’s?
China and Russia Deploy Seductive Espionage Networks to Infiltrate U.S. Tech Sector
Apple’s ‘iPhone Air’ Collapses After One Month — Another Major Misstep for the Tech Giant
Graham Potter Begins New Chapter as Sweden Head Coach on Short-Term Deal
Ecuadorian President Daniel Noboa Alleges Poison Plot via Chocolate and Jam
Lakestar to Halt External Fundraising as Investor in Revolut and Spotify
U.S. Innovation Ranking Under Scrutiny as China Leads Output Outputs but Ranks 10th
Three Men Arrested in London on Suspicion of Spying for Russia
Porsche Reverses EV Strategy as New CEO Bets on Petrol and Hybrids
Singapore’s Prime Minister Warns of ‘Messy’ Transition to Post-American Global Order
Andreessen Horowitz Sets Sights on Ten-Billion-Dollar Fund for Tech Surge
US Administration Under President Donald Trump Reportedly Lifts Ban on Ukraine’s Use of Storm Shadow Missiles Against Russia
‘Frightening’ First Night in Prison for Sarkozy: Inmates Riot and Shout ‘Little Nicolas’
White House Announces No Imminent Summit Between Trump and Putin
US and Qatar Warn EU of Trade and Energy Risks from Tough Climate Regulation
Apple Challenges EU Digital Markets Act Crackdown in Landmark Court Battle
Nicolas Sarkozy begins five-year prison term at La Santé in Paris
Japan stocks surge to record as Sanae Takaichi becomes Prime Minister
This Is How the 'Heist of the Century' Was Carried Out at the Louvre in Seven Minutes: France Humiliated as Crown with 2,000 Diamonds Vanishes
China Warns UK of ‘Consequences’ After Delay to London Embassy Approval
France’s Wealthy Shift Billions to Luxembourg and Switzerland Amid Tax and Political Turmoil
"Sniper Position": Observation Post Targeting 'Air Force One' Found Before Trump’s Arrival in Florida
Shouting Match at the White House: 'Trump Cursed, Threw Maps, and Told Zelensky – "Putin Will Destroy You"'
Windows’ Own ‘Siri’ Has Arrived: You Can Now Talk to Your Computer
Thailand and Singapore Investigate Cambodian-Based Prince Group as U.S. and U.K. Sanctions Unfold
‘No Kings’ Protests Inflate Numbers — But History Shows Nations Collapse Without Strong Executive Power
Chinese Tech Giants Halt Stablecoin Launches After Beijing’s Regulatory Intervention
Manhattan Jury Holds BNP Paribas Liable for Enabling Sudanese Government Abuses
Trump Orders Immediate Release of Former Congressman George Santos After Commuting Prison Sentence
S&P Downgrades France’s Credit Rating, Citing Soaring Debt and Political Instability
Ofcom Rules BBC’s Gaza Documentary ‘Materially Misleading’ Over Narrator’s Hamas Ties
Diane Keaton’s Cause of Death Revealed as Pneumonia, Family Confirms
Former Lostprophets Frontman Ian Watkins Stabbed to Death in British Prison
"The Tsunami Is Coming, and It’s Massive": The World’s Richest Man Unveils a New AI Vision
Outsider, Heroine, Trailblazer: Diane Keaton Was Always a Little Strange — and Forever One of a Kind
Dramatic Development in the Death of 'Mango' Founder: Billionaire's Son Suspected of Murder
Two Years of Darkness: The Harrowing Testimonies of Israeli Hostages Emerging From Gaza Captivity
EU Moves to Use Frozen Russian Assets to Buy U.S. Weapons for Ukraine
Europe Emerges as the Biggest Casualty in U.S.-China Rare Earth Rivalry
HSBC Confronts Strategic Crossroads as NAB Seeks Only Retail Arm in Australia Exit
U.S. Chamber Sues Trump Over $100,000 H-1B Visa Fee
Shenzhen Expo Spotlights China’s Quantum Step in Semiconductor Self-Reliance
China Accelerates to the Forefront in Global Nuclear Fusion Race
×